Chinese Cardiologists' Knowledge/Practices on Flu Vaccine for Chronic Coronary Syndrome

NCT ID: NCT06991088

Last Updated: 2025-06-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

5000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-06-30

Study Completion Date

2027-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This long-term single-center cross-sectional study evaluates physicians' knowledge of influenza vaccination in CCS patients through collected feedback, while identifying knowledge gaps and misconceptions regarding vaccination. By analyzing factors influencing physicians' recommendation practices, it provides evidence to guide future educational and policy interventions. Ultimately, the study aims to enhance cardiologists' vaccination awareness, thereby optimizing CCS patient management and reducing influenza-associated complications and mortality.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This project conducts a comprehensive literature review to examine current research and practices regarding influenza vaccination for chronic coronary syndrome (CCS) patients among cardiologists worldwide. The review provides theoretical support for study design and helps identify potential causes of low vaccination rates among CCS patients in China.Based on research objectives, investigators developed a structured questionnaire covering four key dimensions:Basic demographic information、Knowledge assessment、Clinical practice patterns、Attitudes and recommendations.The survey targets cardiologists from major Chinese hospitals, employing random or stratified sampling to ensure representative sampling. Data collection will be conducted through online and offline questionnaire distribution.Statistical analysis will be performed using SPSS or equivalent software, including:Descriptive statistics、t-tests、Chi-square tests to examine how different background factors influence knowledge and practices.Findings will systematically summarize Chinese cardiologists' current understanding and behavioral patterns regarding influenza vaccination for CCS patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chinese Cardiologists

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Chief Physician (Professor-level)

Responses from chief physicians (professor-level) across various regions, age groups, hospital types, and years of practice in China were collected via questionnaire survey. The study assessed their knowledge level regarding influenza vaccine application in CCS patients, investigated their perceptions on whether vaccination benefits patients' health outcomes, evaluated current vaccination implementation practices, and determined their support for influenza immunization.

No interventions assigned to this group

Associate Chief Physician (Associate Professor-level)

Responses from Associate Chief Physician (Associate Professor-level) across various regions, age groups, hospital types, and years of practice in China were collected via questionnaire survey. The study assessed their knowledge level regarding influenza vaccine application in CCS patients, investigated their perceptions on whether vaccination benefits patients' health outcomes, evaluated current vaccination implementation practices, and determined their support for influenza immunization.

No interventions assigned to this group

Attending Physician

Responses from Attending Physician across various regions, age groups, hospital types, and years of practice in China were collected via questionnaire survey. The study assessed their knowledge level regarding influenza vaccine application in CCS patients, investigated their perceptions on whether vaccination benefits patients' health outcomes, evaluated current vaccination implementation practices, and determined their support for influenza immunization.

No interventions assigned to this group

Resident Physician

Responses from chief Resident Physician across various regions, age groups, hospital types, and years of practice in China were collected via questionnaire survey. The study assessed their knowledge level regarding influenza vaccine application in CCS patients, investigated their perceptions on whether vaccination benefits patients' health outcomes, evaluated current vaccination implementation practices, and determined their support for influenza immunization.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Cardiologists (licensed practitioners) with specialized knowledge of the association between influenza vaccination and cardiovascular diseases.

Exclusion Criteria

* Physicians from non-cardiology specialties (e.g., surgery, general internal medicine \[including respiratory and gastroenterology departments\], emergency medicine).
* Physicians unable to complete the questionnaire survey.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Affiliated Hospital of Hangzhou Normal University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

MingWei Wang

Hanzhou, Zhejiang, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mingwei W Wang, PhD

Role: CONTACT

18758871517 ext. not

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

MingWei W Wang, PhD

Role: primary

86-18758871517 ext. NOT

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AH-2025-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Gut Microbiota and Metabolites in HFpEF
NCT06645535 ENROLLING_BY_INVITATION
Heart Failure Evaluation Study
NCT05583513 COMPLETED